Showing results (101-110 of 131) with videos related to
Sort By:
Pageof 14
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After LaunchMarina Richardson, Abigail C Wright, Jeffrey A Tice, et al.Journal of Comparative Effectiveness Research|April 1, 2015
Translating comparative effectiveness research into Medicaid payment policy: views from medical and pharmacy directorsJoel S Weissman, Kimberly Westrich, J Lee Hargraves, et al.The American Journal of Managed Care|May 10, 2007
The response of physician groups to P4P incentivesAteev Mehrotra, Steven D Pearson, Kathryn L Coltin, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 18, 2022
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder CancerMrinmayee Joshi, Steven J Atlas, Molly Beinfeld, et al.Journal of General Internal Medicine|June 28, 2007
Does affiliation of physician groups with one another produce higher quality primary care?Mark W Friedberg, Kathryn L Coltin, Steven D Pearson, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 8, 2016
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysisMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and valueAvery McKenna, Grace A Lin, Melanie D Whittington, et al.Journal of Managed Care & Specialty Pharmacy|April 30, 2020
The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut AllergyJeffrey A Tice, Gregory F Guzauskas, Ryan N Hansen, et al.Annals of Internal Medicine|June 20, 2013
Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysisJulia H Hayes, Daniel A Ollendorf, Steven D Pearson, et al.Pageof 14